SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------------------------------------------------------------------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): August 13, 2003
---------------
Bio-Imaging Technologies, Inc.
------------------------------
(Exact Name of Registrant as Specified in Charter)
Delaware 1-11182 11-2872047
--------------------------------------------------------------------------------
(State or Other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification No.)
826 Newtown-Yardley Road, Newtown, PA 18940
--------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(267) 757-3000
--------------
(Registrant's telephone number,
including area code)
----------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
ITEM 9. REGULATION FD DISCLOSURE (INFORMATION FURNISHED PURSUANT TO ITEM 12,
"DISCLOSURE OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION").
On August 13, 2003, Bio-Imaging Technologies, Inc. (the "Company")
announced its financial results for the quarter ended June 30, 2003. The full
text of the press release issued in connection with the announcement is attached
as Exhibit 99.1 to this Current Report on Form 8-K.
In accordance with the procedural guidance in SEC Release Nos. 33-8216 and
34-47583, the information in this Form 8-K and the Exhibit attached hereto is
being furnished under "Item 9. Regulation FD Disclosure" rather than under "Item
12. Disclosure of Results of Operations and Financial Condition." The
information shall not be deemed "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise
subject to the liabilities of that section, nor shall it be deemed incorporated
by reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as expressly set forth by specific reference in such a
filing.
- 2 -
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BIO-IMAGING TECHNOLOGIES, INC.
Dated: August 13, 2003 By: /s/ Mark L. Weinstein
---------------------------------------------
Name: Mark L. Weinstein
Title: President and Chief Executive Officer
EXHIBIT INDEX
Exhibit No. Description
----------- -----------
99.1 Press release dated August 13, 2003.